Literature DB >> 4445986

The assay of antithrombin using a synthetic chromogenic substrate for thrombin.

M Blombäck, B Blombäck, P Olsson, L Svendsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4445986     DOI： 10.1016/0049-3848(74)90052-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  10 in total

1.  Associated von Willebrand disease as a possible cause of lack of thrombosis in an AT III abnormality (AT III Trento).

Authors:  A Girolami; M G Cappellato; M A Vicarioto; S Casonato; F Marafioti
Journal:  Blut       Date:  1986-01

2.  Electrode adsorption method for determination of enzymatic activity.

Authors:  H Arwin; I Lundström; A Palmqvist
Journal:  Med Biol Eng Comput       Date:  1982-05       Impact factor: 2.602

3.  Determination of antithrombin activity by an amidolytic and a clotting procedure.

Authors:  A Frigola; S Angeloni; A R Cerqueti
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

4.  Cytokine and coagulation characteristics of retrieved blood after arthroplasty.

Authors:  M Kristiansson; M Soop; L Saraste; K G Sundqvist; A M Suontaka; M Blomback
Journal:  Intensive Care Med       Date:  1995-12       Impact factor: 17.440

5.  Increased thromboplastic potential in diabetes: a multifactorial phenomenon.

Authors:  M M Landgraf-Leurs; T Ladik; B Smolka; T Bock; W Schramm; M Spannagl; R Landgraf
Journal:  Klin Wochenschr       Date:  1987-07-01

6.  Arginine residues are critical for the heparin-cofactor activity of antithrombin III.

Authors:  A M Jorgensen; C L Borders; W W Fish
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

7.  Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic disease.

Authors:  A Girolami; F Fabris; G Cappellato; L Sainati; G Boeri
Journal:  Blut       Date:  1983-08

8.  Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.

Authors:  M E Switzer; P A McKee
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

9.  Complex-formation and inhibition of urokinase by blood plasma proteins.

Authors:  E K Waller; W D Schleuning; E Reich
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

10.  Comparison of three methods for the estimation of plasma antithrombin.

Authors:  D S McLellan; J D Devlin; G H Heyse-Moore; A Aronstam
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.